---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-009564"
form_type: "8-K"
ticker: "CVM"
cik: "0000725363"
company_name: "CEL SCI CORP"
filed_at: "2024-07-29T23:59:59+00:00"
generated_at: "2026-05-31T15:49:52.739227+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CEL-SCI closes $10.8M public offering of common stock and pre-funded warrants

## Summary
- Gross proceeds of $10,845,000 from offering of 10,845,000 shares/common stock or pre-funded warrants at $1.00/share.
- Net proceeds to fund continued development of lead cancer drug Multikine and for general corporate purposes.
- Offering closed on July 29, 2024; ThinkEquity acted as sole placement agent.
- Officers and directors subject to 90-day lock-up on company securities.
- Pre-funded warrants exercisable at $0.01 per share and expire when fully exercised.

## SEC filing metadata
- accession: 0001654954-24-009564
- form_type: 8-K
- ticker: CVM
- cik: 0000725363
- company_name: CEL SCI CORP
- filed_at: 2024-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/725363/000165495424009564/0001654954-24-009564-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/725363/000165495424009564/cvm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-009564
- JSON: https://secwatch.observer/filing/0001654954-24-009564.json
- Plain text: https://secwatch.observer/filing/0001654954-24-009564.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.